Center Star Asset Management, LLC Biogen Inc. Call Options Transaction History

Center Star Asset Management, LLC

11 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2022 Apr 25, 2022	SELL	$193.77 - $244.14 $1.28 Million - $1.61 Million	-6,600 Closed	0 $0
Q4 2021 Jan 26, 2022	BUY	$223.92 - $287.77 $1.48 Million - $1.9 Million	6,600 New	6,600 $1.93 Million
Q4 2020 Jan 27, 2021	SELL	$236.26 - $355.63 $118,130 - $177,815	-500 Closed	0 $0
Q3 2020 Oct 26, 2020	BUY	$264.77 - $305.71 $132,385 - $152,855	500 New	500 $132,000
Q2 2020 Aug 05, 2020	SELL	$258.66 - $342.55 $129,330 - $171,275	-500 Closed	0 $0
Q1 2020 Apr 13, 2020	BUY	$268.85 - $341.04 $134,425 - $170,520	500 New	500 $20,000
Q4 2018 Jan 16, 2019	SELL	$278.5 - $352.75 $139,250 - $176,375	-500 Closed	0 $0
Q3 2018 Oct 15, 2018	SELL	$293.51 - $383.83 $3.08 Million - $4.03 Million	-10,500 Reduced 95.45%	500 $9,000
Q2 2018 Jul 09, 2018	SELL	$257.52 - $306.91 $4.64 Million - $5.52 Million	-18,000 Reduced 62.07%	11,000 $15,000
Q1 2018 May 01, 2018	BUY	$260.13 - $367.91 $6.27 Million - $8.87 Million	24,100 Added 491.84%	29,000 $195,000
Q4 2017 Feb 06, 2018	BUY	$307.64 - $344.58 $1.51 Million - $1.69 Million	4,900	4,900 $104,000

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Center Star Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Center Star Asset Management, LLC with notifications on news.